Free Trial

Rational Advisors Inc. Makes New Investment in Ryan Specialty Holdings Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background

Rational Advisors Inc. acquired a new stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,500 shares of the company's stock, valued at approximately $997,000.

Several other institutional investors have also recently made changes to their positions in RYAN. Vanguard Group Inc. grew its position in Ryan Specialty by 5.7% in the 4th quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock valued at $633,933,000 after purchasing an additional 529,631 shares during the period. Bessemer Group Inc. lifted its position in Ryan Specialty by 2.5% in the 4th quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company's stock valued at $210,651,000 after acquiring an additional 79,976 shares in the last quarter. Principal Financial Group Inc. increased its holdings in Ryan Specialty by 66.4% during the 1st quarter. Principal Financial Group Inc. now owns 3,051,356 shares of the company's stock worth $225,404,000 after purchasing an additional 1,218,147 shares in the last quarter. Blair William & Co. IL raised its stake in shares of Ryan Specialty by 0.6% in the fourth quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock worth $177,464,000 after purchasing an additional 16,540 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Ryan Specialty by 2.7% in the fourth quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company's stock valued at $115,468,000 after purchasing an additional 46,960 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Ryan Specialty Stock Down 1.2%

RYAN opened at $63.84 on Friday. The company has a 50 day moving average of $68.08 and a 200 day moving average of $68.11. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 3.45. Ryan Specialty Holdings Inc. has a 12 month low of $55.95 and a 12 month high of $77.16. The company has a market cap of $16.75 billion, a PE ratio of 187.77, a price-to-earnings-growth ratio of 1.72 and a beta of 0.66.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, meeting analysts' consensus estimates of $0.39. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The business had revenue of $690.17 million during the quarter, compared to analyst estimates of $680.80 million. During the same quarter in the previous year, the firm earned $0.35 EPS. The company's quarterly revenue was up 25.0% compared to the same quarter last year. On average, sell-side analysts expect that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.

Ryan Specialty Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 0.75%. The ex-dividend date was Tuesday, May 13th. Ryan Specialty's payout ratio is 141.18%.

Analysts Set New Price Targets

A number of research firms recently commented on RYAN. Keefe, Bruyette & Woods lowered their price target on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Morgan Stanley raised their price target on shares of Ryan Specialty from $78.00 to $80.00 and gave the company an "overweight" rating in a research report on Monday, May 19th. TD Cowen began coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 target price on the stock. The Goldman Sachs Group raised Ryan Specialty from a "neutral" rating to a "buy" rating and upped their target price for the company from $74.00 to $81.00 in a report on Tuesday, May 13th. Finally, Wells Fargo & Company dropped their price target on Ryan Specialty from $65.00 to $63.00 and set an "equal weight" rating on the stock in a report on Thursday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $75.00.

Get Our Latest Report on Ryan Specialty

Insiders Place Their Bets

In related news, EVP Mark Stephen Katz sold 14,377 shares of the company's stock in a transaction on Friday, June 13th. The shares were sold at an average price of $65.84, for a total value of $946,581.68. Following the completion of the transaction, the executive vice president directly owned 1,117 shares in the company, valued at approximately $73,543.28. The trade was a 92.79% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director David P. Bolger sold 5,000 shares of the stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the transaction, the director directly owned 71,467 shares in the company, valued at approximately $5,059,863.60. This represents a 6.54% decrease in their position. The disclosure for this sale can be found here. 52.21% of the stock is owned by insiders.

Ryan Specialty Company Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines